STOCK TITAN
  1. Home
  2. News
  3. XXII

22nd Century Group Inc - XXII STOCK NEWS

Welcome to our dedicated news page for 22nd Century Group (Ticker: XXII), a resource for investors and traders seeking the latest updates and insights on 22nd Century Group.

Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect 22nd Century Group's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.

Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of 22nd Century Group's position in the market.

News
22nd Century Announces Executive Leadership Changes
Rhea-AI Summary
22nd Century Group, Inc. expands its board with the appointment of John Miller as interim CEO and adds Andy Arno as an independent director. The company has secured $11.7 million in gross proceeds from a registered direct financing and has implemented a $15 million annualized cost reduction initiative. The balance sheet has been strengthened, and operating expenses have been reduced.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-35.57%
Tags
management
-
News
22nd Century Group (XXII) Regains Compliance with Nasdaq Listing Standards
Rhea-AI Summary
22nd Century Group regains compliance with Nasdaq listing requirements.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
35.04%
Tags
none
-
News
A Cigarette to Help Californians Smoke Less: 22nd Century Group, Inc. Launches Reduced Nicotine VLN® King Cigarettes in California, VLN Will Be Sold at #1 U.S. Convenience Store Chain and Other Responsible Retail Locations
Rhea-AI Summary
Biotech company 22nd Century Group, Inc. has launched VLN® King cigarettes, the first-ever reduced nicotine combustible cigarette, in the California market. VLN® cigarettes contain 95% less nicotine than conventional cigarettes and have received FDA approval as a modified risk tobacco product. They will be available at over 275 convenience store locations in California.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
3.23%
Tags
none
News
22nd Century Group (XXII) VLN® Products Now Selling in Montana C-Stores
Rhea-AI Summary
22nd Century Group, Inc. announces that its VLN® reduced nicotine content cigarettes are selling well in over 80 Town Pump convenience-stores across Montana. The availability of VLN® is expanding, providing adult smokers with a new tool to reduce nicotine addiction.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
8.89%
Tags
none
-
News
22nd Century Group (XXII) Announces New Agreement with Hub, Inc. to Expand Midwest Distribution
Rhea-AI Summary
22nd Century Group, Inc. has announced a new distribution agreement with Hub, Inc., a Midwest-based convenience store and multi-channel distributor. The agreement allows eligible Hub customers to purchase 22nd Century's VLN® products as part of the company's state and regional rollout program. Hub is a leading distributor of cigarettes in the Midwest, serving over 2,500 customer locations in several states. The partnership is expected to expand retail points of sale for 22nd Century's reduced nicotine content cigarettes.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.86%
Tags
none
-
News
22nd Century Announces $3.0 Million Registered Direct Offering Priced Above Market
Rhea-AI Summary
22nd Century Group, Inc. announces registered direct offering of common stock and warrants for $3.0 million
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-28.19%
Tags
offering
News
22nd Century Announces 1-for-15 Reverse Stock Split
Rhea-AI Summary
22nd Century Group, Inc. announced a reverse stock split to regain compliance with Nasdaq listing standards. The company reaffirmed its full-year outlook of $105 million to $110 million in net sales. The stock will begin trading on a reverse stock split-adjusted basis on July 5, 2023.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-22.19%
Tags
none
-
News
22nd Century Group (XXII) Announces Production of VLN® Homogenized Tobacco Leaf Sheet
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-6.47%
Tags
none
-
News
VLN® Products Launch in Nevada to Help Smokers Smoke Less
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
0.67%
Tags
none
News
22nd Century Announces $5.3 Million Registered Direct Offering Priced Above Market
Rhea-AI Summary
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-4.05%
Tags
offering
Stock XXII logo
22nd Century Group Inc

Nasdaq:XXII

XXII Rankings

N/A Ranked by Market Cap
#5536 Ranked by Stock Gains
N/A Ranked by Dividends

XXII Stock Data

9.41M
3.28M
0.65%
6.58%
5.51%
Tobacco Manufacturing
Manufacturing
Link
United States
Mocksville

About XXII

with the mission of reducing the harm caused by smoking, 22nd century is a plant biotechnology company whose proprietary technology allows for the levels of nicotine in the tobacco plant to be decreased or increased through genetic engineering and plant breeding. goodrich tobacco company and hercules pharmaceuticals are wholly-owned subsidiaries focusing on (i) premium cigarettes and potentially reduced risk tobacco products (with up to 97% less nicotine than conventional cigarettes), and (ii) the x-22 prescription smoking cessation aid in development. 22nd century's technology also allows the levels of cannabinoids to be decreased or increased in the cannabis plant.